Posted by Michael Wonder on 27 Jun 2023
GSK receives US FDA fast track designation for investigational vaccine against gonorrhoea
27 June 2023 - Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing.
GSK announced today the US FDA has granted a fast track designation for its Neisseria gonorrhoeae investigational vaccine.
